WHC is still in active development. Read this to understand our approach.
depiction of LKYQLAWMNBFNJT-UHFFFAOYSA-N.svg
isomerdesign

Anileridine

Verificar en isomerdesign

pubchem

Anileridine

Verificar en pubchem

drugmap

Anileridine

Verificar en drugmap

wiki

Anileridine

Verificar en wiki

Data

InChI: InChI=1S/C22H28N2O2/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18/h3-11H,2,12-17,23H2,1H3

Sinónimos: Leritin,Anileridinum [INN-Latin], Anileridinum,Anileridine (USP/INN),Anileridina [INN-Spanish],DSSTox_CID_2610,Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylate,CHEMBL1201347, Ethyl 1-(p-aminophenethyl)-4-phenylisonipecotate,Leritine,1-(p-Aminophenethyl)-4-phenylisonipecotic acid ethyl ester,Anileridinum,ANILERIDINE,ANILERIDINE [INN],DSSTox_GSID_22610,ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate,1-P-AMINOPHENETHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER, Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylate,SCHEMBL26333, Leritin,CAS-144-14-9,N-(beta-(p-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine,1-(2-(4-Aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylic acid ethyl ester, Ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate, Alidine, 1-(p-Aminophenethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester,ANILERIDINE [MI], N-(beta-(p-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine,N-beta-(p-Aminophenyl)ethylnormeperidine,ANILERIDINE [MART.],Ethyl 1-(p-aminophenethyl)-4-phenylisonipecotate, Leritine (TN),Apidol, Apidol, Apodol,GTPL7115,ANILERIDINE [HSDB], Anileridina,144-14-9,UNII-71Q1A3O279, 1-[2-(4-Aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxlic acid ethyl ester,Alidine,D02941,Anileridina, Anileridine (USP/INN), Anileridina [INN-Spanish], 4-Piperidinecarboxylic acid, 1-[2-(4-aminophenyl)ethyl]-4-phenyl-, ethyl ester, Nipecotan,ANILERIDINE [USP IMPURITY],IDS-NA-012,ZINC608179,4-Piperidinecarboxylic acid, 1-(2-(4-aminophenyl)ethyl)-4-phenyl-, ethyl ester,4-Piperidinecarboxylic acid, 1-[2-(4-aminophenyl)ethyl]-4-phenyl-, ethyl ester,1-[2-(4-Aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxlic acid ethyl ester,ANILERIDINE [WHO-DD],AKOS027446331,HSDB 3288, 4-Piperidinecarboxylic acid, 1-(2-(4-aminophenyl)ethyl)-4-phenyl-, ethyl ester, 1-(p-Aminophenethyl)-4-phenylisonipecotic acid ethyl ester,Q742266,Ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxylate #, Isonipecotic acid, 1-(p-aminophenethyl)-4-phenyl-, ethyl ester, 1-(2-(4-Aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylic acid ethyl ester,Nipecotan,71Q1A3O279,Anileridine [USP:INN:BAN],Adopol,NCGC00253613-01,CHEBI:61203,1-(p-Aminophenethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester,DSSTox_RID_97535,L000700, Anileridine [INN:BAN],Isonipecotic acid, 1-(p-aminophenethyl)-4-phenyl-, ethyl ester,Apodol,Tox21_113744,DTXSID8022610, Anileridinum [INN-Latin],Anileridine, N-beta-(p-Aminophenyl)ethylnormeperidine, Ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate,DB00913,DEA No. 9020,Ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate

Estimated data

Solubilidad: -4.047 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 87.6% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.